...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: What happened to our renal trial from 2017???

The excrement, I'm sorry, excitement is just unbearable.

$85 billion of potential sales over patent life and that's a conservative estimate.

"Were going to go it alone."

Here we sit on the verge of bancruptcy - victims of a a broken capital market.

What a bunch of crap.

 

Share
New Message
Please login to post a reply